Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BPM31510 + Gemcitabine in Advanced Pancreatic Cancer
NCT02650804Phase 2Completed
- Sponsor
- BPGbio
- Start
- Jul 2016
- Primary completion
- Jun 2019
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of ubidecarenone nanodispersion in pancreatic adenocarcinoma (PDAC), sponsored by BPGbio. Started Jul 2016; status: completed.
02
Drugs
ubidecarenone nanodispersion
03
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT02650804.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02650804.